Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 10/2007

01.10.2007

Histological, CT, and Intraoperative Ultrasound Appearance of Hepatic Tumors Previously Treated by Laparoscopic Radiofrequency Ablation

verfasst von: T. Mason, E. Berber, J. C. Graybill, A. Siperstein

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this paper is to compare intraoperative biopsy results of previously ablated liver tumors with their preoperative computed tomography (CT) and intraoperative laparoscopic ultrasound (LUS) appearances in patients undergoing repeat radiofrequency ablation (RFA).

Methods

Seventy repeat RFA procedures were performed in 59 (13%) patients. Laparoscopically, suspected recurrent and stable appearing foci were biopsied using an 18 G biopsy gun. Preoperative CT and LUS appearances of the previously ablated lesions were compared with core biopsy results.

Results

There were 33 patients with colorectal cancer, 11 with hepatocellular cancer, 8 with neuroendocrine tumors, and 7 with other tumor types. Two hundred lesions were treated by RFA in these 70 repeat ablations. Suspected recurrent tumor foci were enhanced on CT and produced a more finely stippled echo pattern on LUS. Biopsy confirmed recurrent tumor in 72 of 84 such lesions. Previously ablated foci had a CT appearance of a hypodense, nonenhancing lesion without evidence of adjacent enhancing foci. Laparoscopic ultrasound appearance was of a hypoechoic lesion with a coarse internal pattern with the tracks of the ablation catheter probes often still visible. Biopsy found necrotic tissue in 21 of 22 such lesions appearing radiologically to be without recurrence. Biopsy of an ablated focus adjacent to an area of suspected recurrence showed necrotic tissue in 17 of 22 lesions and viable cancer in 5.

Conclusion

CT and LUS appearance of previously ablated foci showed good correlation with core biopsies. CT scan is reliable in following RFA lesions, without the need for routine biopsy. LUS reliably distinguished recurrent from ablated lesions in patients undergoing repeat ablation.
Literatur
1.
Zurück zum Zitat Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969;23(1):198–202.PubMedCrossRef Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969;23(1):198–202.PubMedCrossRef
2.
Zurück zum Zitat Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990 [see comments]. CA Cancer J Clin 1990;40(1):9–26.PubMedCrossRef Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990 [see comments]. CA Cancer J Clin 1990;40(1):9–26.PubMedCrossRef
3.
Zurück zum Zitat Okuda K, Obata H, Nakajima Y, Ohtsuki T, Okazaki N, Ohnishi K. Prognosis of primary hepatocellular carcinoma. Hepatology 1984;4(1 Suppl):3S–6S.PubMed Okuda K, Obata H, Nakajima Y, Ohtsuki T, Okazaki N, Ohnishi K. Prognosis of primary hepatocellular carcinoma. Hepatology 1984;4(1 Suppl):3S–6S.PubMed
4.
Zurück zum Zitat Akerstrom G. Management of carcinoid tumors of the stomach, duodenum, and pancreas. World J Surg 1996;20(2):173–182.PubMedCrossRef Akerstrom G. Management of carcinoid tumors of the stomach, duodenum, and pancreas. World J Surg 1996;20(2):173–182.PubMedCrossRef
5.
Zurück zum Zitat di Bartolomeo M, Bajetta E, Buzzoni R, Mariani L, Carnaghi C, Somma L, Zilembo N, di Leo A. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer 1996;77(2):402–408.PubMedCrossRef di Bartolomeo M, Bajetta E, Buzzoni R, Mariani L, Carnaghi C, Somma L, Zilembo N, di Leo A. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer 1996;77(2):402–408.PubMedCrossRef
6.
Zurück zum Zitat Faiss S, Scherubl H, Riecken EO, Wiedenmann B. Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system. Recent Results Cancer Res 1996;142:193–207.PubMed Faiss S, Scherubl H, Riecken EO, Wiedenmann B. Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system. Recent Results Cancer Res 1996;142:193–207.PubMed
7.
Zurück zum Zitat Steele G Jr, Ravikumar TS, Benotti PN. New surgical treatments for recurrent colorectal cancer. Cancer 1990;65(3 Suppl):723–730.PubMedCrossRef Steele G Jr, Ravikumar TS, Benotti PN. New surgical treatments for recurrent colorectal cancer. Cancer 1990;65(3 Suppl):723–730.PubMedCrossRef
8.
Zurück zum Zitat Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343(8910):1405–1410.PubMedCrossRef Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343(8910):1405–1410.PubMedCrossRef
9.
Zurück zum Zitat Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219(3):236–247.PubMedCrossRef Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219(3):236–247.PubMedCrossRef
10.
Zurück zum Zitat McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990;108(6):1091–1096.PubMed McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990;108(6):1091–1096.PubMed
11.
Zurück zum Zitat Ravikumar TS. Interstitial therapies for liver tumors. Surg Oncol Clin N Am 1996;5(2):365–377.PubMed Ravikumar TS. Interstitial therapies for liver tumors. Surg Oncol Clin N Am 1996;5(2):365–377.PubMed
12.
Zurück zum Zitat McGahan J, Schneider P, Brock J. Treatment of liver tumors by percutaneous RF electrocautery. Semin Intervent Radiol 1993;10(2):143–149.CrossRef McGahan J, Schneider P, Brock J. Treatment of liver tumors by percutaneous RF electrocautery. Semin Intervent Radiol 1993;10(2):143–149.CrossRef
13.
Zurück zum Zitat Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol 1993;8:97–103. Rossi S, Fornari F, Buscarini L. Percutaneous ultrasound guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Interv Radiol 1993;8:97–103.
14.
Zurück zum Zitat Rossi S, Di Stasi M, Buscarini E, Cavanna L, Quaretti P, Squassante E, Garbagnati F, Buscarini L. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995;1(1):73.PubMed Rossi S, Di Stasi M, Buscarini E, Cavanna L, Quaretti P, Squassante E, Garbagnati F, Buscarini L. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995;1(1):73.PubMed
15.
Zurück zum Zitat Berber E, Ari E, Herceg N, Siperstein A. Laparoscopic radiofrequency ablation for unusual hepatic tumors: operative indications and outcome. Surg Endosc 2005;19:1613–1617.PubMedCrossRef Berber E, Ari E, Herceg N, Siperstein A. Laparoscopic radiofrequency ablation for unusual hepatic tumors: operative indications and outcome. Surg Endosc 2005;19:1613–1617.PubMedCrossRef
16.
Zurück zum Zitat Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005;23(7):1358–1364.PubMedCrossRef Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005;23(7):1358–1364.PubMedCrossRef
17.
Zurück zum Zitat Berber E, Flesher NL, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002;26(8):985–990.PubMedCrossRef Berber E, Flesher NL, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002;26(8):985–990.PubMedCrossRef
18.
Zurück zum Zitat Siperstein A, Garland A, Engle K, Rogers S, Berber E, Foroutani A, String A, Ryan T, Ituarte P. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000;7(2):106–113.PubMedCrossRef Siperstein A, Garland A, Engle K, Rogers S, Berber E, Foroutani A, String A, Ryan T, Ituarte P. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000;7(2):106–113.PubMedCrossRef
19.
Zurück zum Zitat Berber E, Foroutani A, Garland AM, Rogers SJ, Engle KL, Ryan TL, Siperstein AE. Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc 2000;14(9):799–804.PubMedCrossRef Berber E, Foroutani A, Garland AM, Rogers SJ, Engle KL, Ryan TL, Siperstein AE. Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc 2000;14(9):799–804.PubMedCrossRef
20.
Zurück zum Zitat Siperstein A, Garland A, Engle K, Rogers S, Berber E, String A, Foroutani A, Ryan T. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations. Surg Endosc 2000;14(4):400–405.PubMedCrossRef Siperstein A, Garland A, Engle K, Rogers S, Berber E, String A, Foroutani A, Ryan T. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations. Surg Endosc 2000;14(4):400–405.PubMedCrossRef
21.
Zurück zum Zitat Berber E, Flesher NL, Siperstein AE. Initial clinical evaluation of the RITA 5-centimeter radiofrequency thermal ablation catheter in the treatment of liver tumors. Cancer J Sci Am 2000;6(S4):S319–S329. Berber E, Flesher NL, Siperstein AE. Initial clinical evaluation of the RITA 5-centimeter radiofrequency thermal ablation catheter in the treatment of liver tumors. Cancer J Sci Am 2000;6(S4):S319–S329.
22.
Zurück zum Zitat Berber E, Herceg NL, Casto KJ, Siperstein AE. Laparoscopic radiofrequency ablation of hepatic tumors: Prospective clinical evaluation of ablation size comparing two treatment algorithms. Surg Endosc 2004;18(3):390–396.PubMedCrossRef Berber E, Herceg NL, Casto KJ, Siperstein AE. Laparoscopic radiofrequency ablation of hepatic tumors: Prospective clinical evaluation of ablation size comparing two treatment algorithms. Surg Endosc 2004;18(3):390–396.PubMedCrossRef
23.
Zurück zum Zitat Ebara M, Kita K, Sugiura N, Yoshikawa M, Fukuda H, Ohto M, Kondo F, Kondo Y. Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT. Radiology 1995;195(2):371–377.PubMed Ebara M, Kita K, Sugiura N, Yoshikawa M, Fukuda H, Ohto M, Kondo F, Kondo Y. Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT. Radiology 1995;195(2):371–377.PubMed
24.
Zurück zum Zitat McLoughlin RF, Saliken JF, McKinnon G, Wiseman D, Temple W. CT of the liver after cryotherapy of hepatic metastases: imaging findings. AJR Am J Roentgenol 1995;165(2):329–332.PubMed McLoughlin RF, Saliken JF, McKinnon G, Wiseman D, Temple W. CT of the liver after cryotherapy of hepatic metastases: imaging findings. AJR Am J Roentgenol 1995;165(2):329–332.PubMed
25.
Zurück zum Zitat Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients [see comments]. Ann Surg 1999;230(1):1–8.PubMedCrossRef Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients [see comments]. Ann Surg 1999;230(1):1–8.PubMedCrossRef
26.
Zurück zum Zitat Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, Cova L, Halpern EF, Gazelle GS. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159–166.PubMedCrossRef Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, Cova L, Halpern EF, Gazelle GS. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159–166.PubMedCrossRef
27.
Zurück zum Zitat Ahmad A, Chen SL, Kavanagh MA, Allegra AP, Bickel A. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am Surg 2006;72:875–879.PubMed Ahmad A, Chen SL, Kavanagh MA, Allegra AP, Bickel A. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am Surg 2006;72:875–879.PubMed
28.
Zurück zum Zitat Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239(6):818–825; discussion 825–827.PubMedCrossRef Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239(6):818–825; discussion 825–827.PubMedCrossRef
29.
Zurück zum Zitat Dromain C, De Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR Imaging follow up. Radiology 2002;223:255–262.PubMedCrossRef Dromain C, De Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR Imaging follow up. Radiology 2002;223:255–262.PubMedCrossRef
Metadaten
Titel
Histological, CT, and Intraoperative Ultrasound Appearance of Hepatic Tumors Previously Treated by Laparoscopic Radiofrequency Ablation
verfasst von
T. Mason
E. Berber
J. C. Graybill
A. Siperstein
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 10/2007
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-007-0214-z

Weitere Artikel der Ausgabe 10/2007

Journal of Gastrointestinal Surgery 10/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.